Chanelle Pharma’s Post

This book -- Meaningful Partnership at Work: How The Workplace Covenant Ensures Mutual Accountability and Success between Leaders and Teams -- has been a powerful asset to building healthy workplace culture! https://lnkd.in/dWMgMEbt Routledge Business & Economics

A world class commercial plan that is not well executed will miss the mark. An average commercial plan that is well executed often will exceed expectations. Execution matters immensely! Are you doing all that you can to elevate your teams performance? Reach out to me or stop by our booth to learn more.

Thrilled to announce our latest report by Morten Nielsen and Mindy Steiger, exploring CDMOs' pivotal role in the pharmaceutical industry. Discover key trends, leadership insights, and recommendations for success. 💡 #ImpactfulLeadership #PharmaLeadership #HealthcareInnovation

“The challenge is, right now, many companies are realizing they have a lot of expensive talent and expertise that is different from what they need going forward, which increases pressure on their ability to respond to the changes in the industry.” Check out more compelling thoughts on current pharma leadership navigation in my Q&A with strategy experts from BTS.

The ISPE Boston Area Chapter leadership committee on 1/31 held a great meeting reviewing general policies and practices. The committee upholds the values of transparency, accountability, and collaboration, which align with its core values and strategic goals to provide education and collaboration within the pharmaceutical industry. During the meeting, constructive ideas, and conversations fostered a culture of inclusivity, trust, and respect. The committee also sought to incorporate diverse perspectives in shaping future continuous improvement. ISPE Boston, understands and prioritizes the importance of working together towards a common goal. Promoting transparency, and collaboration fosters the achievement of these objectives. #lifesciences #growth #collaboration Sanofi #researchanddevelopment #pharmaceuticalindustry #ispe #sanofistories #sanofi Marisa Sposato Linda Lauzier Eric Felz Kevin Mitchell Lateffa S. Curry Eni Adedokun El-Wadi Michael Levesque Jack Campion, P.E. Aaron Hubbell Laura Berberian Brooke Cote Kathryn Marini, Sean Keenan, Katelyn Vallery Jane Kepros ISPE Boston Area Chapter ISPE Emily Wakelin Caren Jenkins.

We are thrilled to announce the release of our most recent report by Morten Nielsen and Mindy Steiger, which delves into the role of Contract Development and Manufacturing Organizations (CDMOs) within the pharmaceutical industry. This comprehensive analysis highlights key industry trends and offers insightful glimpses into the leadership teams and boardrooms of leading CDMOs. CDMOs have become indispensable pillars of the pharmaceutical value chain, standing out as trusted business partners dedicated to meeting the burgeoning demand for innovative medicines and adaptive solutions. Over the past three decades, this industry has undergone a remarkable transformation, necessitating a recalibration of leadership requirements. To thrive, we recommend that CDMOs consider augmenting their leadership teams with competencies in: 💡 Digital Transformation 💡 Artificial Intelligence 💡 ESG/Sustainability 💡 Cutting-edge Modalities (including cell, gene, and mRNA therapies) Prominent players in the Quality of Life Ecosystem, CDMOs are uniquely positioned to drive progress in addressing global healthcare challenges and improving patient outcomes. Please review our detailed talent insights and leadership recommendations to learn more. ⬇ #CDMO #ImpactfulLeadership

We are thrilled to announce the release of our most recent report by Morten Nielsen and Mindy Steiger, which delves into the role of Contract Development and Manufacturing Organizations (CDMOs) within the pharmaceutical industry. This comprehensive analysis highlights key industry trends and offers insightful glimpses into the leadership teams and boardrooms of leading CDMOs. CDMOs have become indispensable pillars of the pharmaceutical value chain, standing out as trusted business partners dedicated to meeting the burgeoning demand for innovative medicines and adaptive solutions. Over the past three decades, this industry has undergone a remarkable transformation, necessitating a recalibration of leadership requirements. To thrive, we recommend that CDMOs consider augmenting their leadership teams with competencies in: 💡 Digital Transformation 💡 Artificial Intelligence 💡 ESG/Sustainability 💡 Cutting-edge Modalities (including cell, gene, and mRNA therapies) Prominent players in the Quality of Life Ecosystem, CDMOs are uniquely positioned to drive progress in addressing global healthcare challenges and improving patient outcomes. Please review our detailed talent insights and leadership recommendations to learn more. ⬇ #CDMO #ImpactfulLeadership

Last chance to register! The pharmaceutical industry is rapidly changing, and staying informed is crucial for success. Join us tomorrow as we delve into how MJ MagniPhy can help you adapt to these changes. We’ll discuss the latest trends, effective strategies for managing pharmacy costs, and how data-driven insights can enhance your decision-making. This is a must-attend event for HR professionals and C-Suite leaders looking to maximize value for their business. Reserve your spot today: https://ow.ly/4StR50SXgXe #PharmacyTrends #Leadership #WebinarAlert

Content so good I should not be giving it out for free (don't tell my boss). Welcome to Part 1 in our "Scrip Asks" article series where we invite industry leaders, investors, experts and other stakeholders to share their expectations for the year ahead. With responses from hundreds of professionals, "Scrip Asks…What Does 2024 Hold For Biopharma?" provides an exceptional insight, both broad and deep, into the biopharma universe’s collective crystal ball. Part 1 is on Business Strategy And Leadership with exclusive insights you won't find anywhere else from: Johnson & Johnson, AbbVie, Genmab, Gilead Sciences to name a few! #biopharma #strategy #innovation

🌍 Rebuilding After COVID In this insightful Q&A as part of our LogiPharma 2024 coverage, Elissa Libby, VP of Storage Operations at Alcami Corporation, shares her journey in leading the company’s recovery efforts post-pandemic. From managing rapid change to navigating the "new normal," Elissa discusses the critical lessons learned and the strategies her team is using to foster resilience and innovation in the supply chain. 🚚💡 Dive into the full conversation to learn more about how Alcami is adapting and thriving: https://bit.ly/3YrIkBN #SupplyChainResilience #Leadership #PostCovidRecovery #Alcami #Innovation #ChangeManagement #LogiPharma #LogiPharma2024 #SupplyChain